Abstract

Sulfur mustard (SM; bis (2‐chloroethyl) sulfide) is a potent vesicating agent that has been used in chemical warfare. Exposure of the eyes to SM can cause corneal erosions, epithelial defects, neovascularization, microblistering, and/or dry eye disease, all injuries that can lead to corneal epithelium sloughing and ultimately blindness. In the present studies, the effects of ocular exposure to SM vapor (0.420 mg/L for 8 min) on the corneas of male New Zealand white rabbits was characterized at 1, 3, 7, 14, 21 and 28 days post‐exposure. During this time, corneal thickness increased from ~400 microns to 600–900 microns. Unexposed control corneas were clear throughout the time course. However, after SM exposure increased corneal thickness was associated with decreased corneal opacity and neovascularization. Histologically, SM exposure induced epithelial‐stromal separation at 3 days, by which time 16% of the epithelia had separated from the stroma, and by 28 days detachment had decreased to 9%. Also observed was post‐SM epithelial thinning, increased stromal disorganization, and edema. Sporadic keratocytes were also evident in the edematous stroma by day 14. At 28 days post‐SM, an inflammatory cell infiltrate was observed in the stroma. In control corneas, keratin 17, a marker of wound repair, was constitutively expressed in the limbus and bulbar conjunctiva. By 14 days post‐SM, keratin 17 was expressed in the peripheral corneal epithelium, and by 28 days it was expressed in the central cornea. PCNA, a proliferation marker, was constitutively expressed in the nuclei of control corneal epithelial cells. Three days post‐SM, PCNA expression was decreased along the damaged basal layer. Twenty eight days post‐SM, PCNA was upregulated in the nuclei of hyperplastic cells of the central cornea and cells of the limbus, indicating wound repair. These data suggest that limbal and /or conjunctival epithelial cells play a role in the repair of SM‐induced corneal injury. A better understanding of the mechanisms of SM‐induced corneal damage will lead to the development of new therapeutics for the treatment of these debilitating ocular injuries. Supported by NIH grant AR055073.Support or Funding InformationSupported by NIH grant AR055073.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.